Mitsubishi Chemical Group Corporation

DB:M3C Stock Report

Market Cap: €6.7b

Mitsubishi Chemical Group Valuation

Is M3C undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of M3C when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: M3C (€4.55) is trading below our estimate of fair value (€10.56)

Significantly Below Fair Value: M3C is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for M3C?

Key metric: As M3C is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for M3C. This is calculated by dividing M3C's market cap by their current earnings.
What is M3C's PE Ratio?
PE Ratio11.7x
EarningsJP¥93.31b
Market CapJP¥1.09t

Price to Earnings Ratio vs Peers

How does M3C's PE Ratio compare to its peers?

The above table shows the PE ratio for M3C vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average41.1x
BAS BASF
76.4x31.4%€38.0b
EVK Evonik Industries
33.5x32.9%€7.7b
FPE3 Fuchs
18.3x8.6%€4.8b
SY1 Symrise
36.2x13.6%€14.2b
M3C Mitsubishi Chemical Group
11.7x19.3%€1.1t

Price-To-Earnings vs Peers: M3C is good value based on its Price-To-Earnings Ratio (11.7x) compared to the peer average (41.1x).

Price to Earnings Ratio vs Industry

How does M3C's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
M3C 11.7xIndustry Avg. 16.9xNo. of Companies12PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: M3C is good value based on its Price-To-Earnings Ratio (11.7x) compared to the European Chemicals industry average (16.9x).

Price to Earnings Ratio vs Fair Ratio

What is M3C's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

M3C PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.7x
Fair PE Ratio19.8x

Price-To-Earnings vs Fair Ratio: M3C is good value based on its Price-To-Earnings Ratio (11.7x) compared to the estimated Fair Price-To-Earnings Ratio (19.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst M3C forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€4.55
€6.60
+45.0%
14.6%€8.15€4.83n/a10
Dec ’25€4.86
€6.60
+35.7%
14.9%€8.11€4.80n/a10
Nov ’25€4.83
€6.50
+34.6%
11.6%€8.00€5.60n/a10
Oct ’25€5.59
€6.63
+18.6%
12.2%€8.22€5.75n/a10
Sep ’25€5.14
€6.25
+21.6%
11.9%€8.05€5.51n/a10
Aug ’25€5.45
€6.00
+10.2%
7.9%€6.94€5.37n/a10
Jul ’25€5.14
€5.71
+11.0%
9.2%€6.67€4.99n/a9
Jun ’25€5.02
€5.83
+16.0%
8.2%€6.56€4.95n/a9
May ’25€5.28
€5.83
+10.3%
8.2%€6.56€4.95n/a9
Apr ’25€5.50
€5.83
+6.0%
8.2%€6.56€4.95n/a9
Mar ’25€5.17
€5.94
+14.9%
12.6%€7.79€5.04n/a10
Feb ’25€5.46
€6.14
+12.5%
13.2%€7.88€5.19n/a10
Jan ’25€5.67
€6.32
+11.5%
12.9%€8.13€5.35n/a10
Dec ’24€5.78
€5.95
+2.9%
13.0%€7.90€4.95€4.8611
Nov ’24€5.61
€5.95
+6.1%
13.0%€7.90€4.95€4.8311
Oct ’24€5.81
€5.85
+0.7%
15.7%€7.98€4.75€5.5910
Sep ’24€5.45
€5.57
+2.1%
12.7%€6.59€4.50€5.1410
Aug ’24€5.34
€5.51
+3.2%
13.3%€6.60€4.51€5.4510
Jul ’24€5.38
€5.50
+2.4%
12.2%€6.63€4.53€5.1410
Jun ’24€5.15
€5.82
+12.9%
16.9%€7.74€4.00€5.0210
May ’24€5.20
€5.84
+12.5%
17.7%€7.73€4.00€5.289
Apr ’24€5.40
€6.08
+12.5%
17.4%€8.11€4.33€5.509
Mar ’24€5.45
€5.93
+8.7%
18.3%€7.99€4.27€5.179
Feb ’24€5.05
€5.52
+9.3%
12.5%€6.50€3.90€5.4610
Jan ’24n/a
€5.45
0%
12.8%€6.76€4.27€5.6710
Dec ’23€5.05
€5.40
+6.8%
12.2%€6.62€4.18€5.7811

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 09:56
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mitsubishi Chemical Group Corporation is covered by 25 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mikiya YamadaBarclays
Takashi EnomotoBofA Global Research
Atsushi IkedaCitigroup Inc